Your SlideShare is downloading. ×
Christian Haas Webinar July 2014
Christian Haas Webinar July 2014
Christian Haas Webinar July 2014
Christian Haas Webinar July 2014
Christian Haas Webinar July 2014
Christian Haas Webinar July 2014
Christian Haas Webinar July 2014
Christian Haas Webinar July 2014
Christian Haas Webinar July 2014
Christian Haas Webinar July 2014
Christian Haas Webinar July 2014
Christian Haas Webinar July 2014
Christian Haas Webinar July 2014
Christian Haas Webinar July 2014
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Christian Haas Webinar July 2014

2,040

Published on

Presentation made by Christian Haas at the Alzforum webinar of July 8, 2014 - http://www.alzforum.org/webinars/mutations-impair-trem2-maturation-processing-and-microglial-phagocytosis

Presentation made by Christian Haas at the Alzforum webinar of July 8, 2014 - http://www.alzforum.org/webinars/mutations-impair-trem2-maturation-processing-and-microglial-phagocytosis

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
2,040
On Slideshare
0
From Embeds
0
Number of Embeds
4
Actions
Shares
0
Downloads
4
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Ludwig-Maximilians-University Munich DZNE - German Center for Neurodegenerative Diseases, Munich & Adolf-Butenandt-Institute, Biochemistry, Ludwig-Maximilians University Munich TREM2 – a general player in neurodegeneration? Christian Haass & Gernot Kleinberger
  • 2. Haass, Nat. Med., 2010; Haass & Aguzzi, Science, 2003 Haass & Selkoe, Nature Reviews Mol. Cell Biology, 2007; Winklhofer, Tatzelt & Haass, EMBO J., 2008 A RIP substrate affected in several neurodegenerative disorders: a novel common mechanism? Prion Disorders PrP PD and others a-synuclein FTLD/ALS TDP- 43/FUS/DP R AD FTLD ta u Ab/tau
  • 3. Regulated Intramembrane Proteolysis (RIP) Prion Disorders PD and others FTLD-U/ALSAD FTLD Nucleus transcription Trscr. Factor 1. shedding 2. intramem. cleavage Haass, EMBO J, 2004
  • 4. Triggering Receptor Expressed on Myeloid cells 2 (TREM2) • Attenuating inflammatory reactions • Promoting phagocytosis • selectively expressed in myeloid cells and microglia • Homozygous loss-of-function mutations in TREM2 are associated with Nasu-Hakola disease / polycystic lipomembraneous osteodysplasia (PLOSL) • Heterozygous mutations are associated with increased risk for late-onset AD • Linkage to FTD-like syndrome without bone involvement • Linkage to FTD • Linkage to ALS • Linkage to PD
  • 5. TREM2 variants
  • 6. Shedding of TREM2 by ADAM10 Gernot Kleinberger Wunderlich et al., J Biol Chem, 2013 Kleinberger et al., Science Translational Medicine, 2014
  • 7. FTD and FTD-like associated missense mutations impair TREM2 maturation and shedding
  • 8. Mutations inhibit cell surface transport of TREM2
  • 9. TREM2 mutations block phagocytosis (bead uptake assay in HEK 293)
  • 10. TREM2 mutations block phagocytosis of E. coli (HEK 293)
  • 11. TREM2 loss of function reduces phagocytosis in primary microglia pHrodo E.coli assay • In accordance with reduced uptake of neuronal apoptotic cell debris upon Trem2 knockdown (Takahashi K. et al. JEM 2005)
  • 12. Reduced Amyloid b-peptide uptake
  • 13. Reduced levels of soluble TREM2 in CSF of AD and FTD patients
  • 14. Therapeutic modulation of TREM2 function?

×